` RPRX (Royalty Pharma PLC) vs MRK (Merck & Co Inc) Comparison - Alpha Spread

RPRX
vs
MRK

Over the past 12 months, RPRX has significantly outperformed MRK, delivering a return of +44% compared to the MRK's 35% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RPRX
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RPRX Intrinsic Value
65.528 USD
Undervaluation 45%
Intrinsic Value
Price
MRK Intrinsic Value
122.35 USD
Undervaluation 34%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Royalty Pharma PLC
NASDAQ:RPRX
36.345 USD
Merck & Co Inc
NYSE:MRK
81.15 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RPRX vs MRK

RPRX
MRK
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Royalty Pharma PLC
Revenue
Merck & Co Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
RPRX vs MRK

RPRX
MRK
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Royalty Pharma PLC
NASDAQ:RPRX
Merck & Co Inc
NYSE:MRK
What is Free Cash Flow?

Gross Margin

RPRX
0%
MRK
78.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

Operating Margin

RPRX
84%
MRK
33.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

Net Margin

RPRX
48.3%
MRK
27.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

FCF Margin

RPRX
12.4%
MRK
26.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

ROE

RPRX
16.6%
MRK
39.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

ROA

RPRX
6.5%
MRK
15.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

ROIC

RPRX
12.5%
MRK
18.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

ROCE

RPRX
11.7%
MRK
25.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Royalty Pharma PLC
Merck & Co Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
RPRX vs MRK

Loading

Performance Gap
RPRX vs MRK

Loading
RPRX
MRK
Difference
www.alphaspread.com

Performance By Year
RPRX vs MRK

Loading
RPRX
MRK
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RPRX to other stocks
Unlock Full Access to Alpha Spread
Create Free Account